Header Logo

Connection

STEPHEN HAHN to Models, Theoretical

Back to Details
This is a "connection" page, showing publications STEPHEN HAHN has written about Models, Theoretical.
STEPHEN HAHN
Connection Strength
0.010
Models, Theoretical
  1. Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days. Clin Cancer Res. 2002 Aug; 8(8):2524-9.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.